MercadoLibre is dominating e-commerce and digital financial services in Latin America, with a strong brand and extensive scale. In Q3, the company saw a 40% YoY revenue increase, hitting $7.4 billion. Eli Lilly, known for its GLP-1 treatments, is also excelling, with Q3 revenue up 54% YoY. The company has a diverse drug portfolio and promising pipeline, including a potential game-changing oral GLP-1 treatment. Both stocks offer growth potential and are worth considering for investors looking for strong performers in the market.

Read more at Nasdaq, Inc.: These Are 2 of the Smartest Growth Stocks to Invest $5,000 in Today